MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.intimp.2025.115732

Медицинская библиотека · International immunopharmacology · 2025

Discovery of o-aminodiphenyl-based USP7 inhibitor for immune activation and antitumor response in colorectal cancer.

Jia Gang, Wang Yuanying, Zhou Weiwei, Huang Xiaomei, Song Zhiyu

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Colorectal cancer is a leading cause of cancer mortality, with microsatellite-stable tumors exhibiting poor response to immune checkpoint inhibitors. Ubiquitin-specific protease 7 (USP7) stabilizes programmed death-ligand 1 (PD-L1), promoting immune evasion.

METHODS

Through screening, synthesis, and optimization, we identified an o-aminodiphenyl derivative, U-20, as a potent USP7 inhibitor (IC₅₀ = 83 nM). USP7 inhibition, PD-L1 modulation, and immune activation were evaluated using in vitro enzymatic and cellular assays, T-cell killing assays, and an immunocompetent CT26 colorectal cancer mouse model.

RESULTS

U-20 selectively bound USP7, destabilized PD-L1 via proteasome-mediated degradation, and increased PD-L1 polyubiquitination without affecting transcription. In colorectal cancer cell-T-cell co-cultures, U-20 enhanced CD8+ T-cell cytotoxicity and cytokine secretion (IFN-γ, TNF-α), effects abolished by ubiquitination-resistant PD-L1 mutants. In vivo, U-20 significantly inhibited tumor growth, increased intratumoral CD8+ T-cell infiltration, and elevated effector cytokine levels, without apparent toxicity.

CONCLUSION

U-20 effectively reprograms the colorectal cancer immune microenvironment by blocking USP7-mediated PD-L1 stabilization, thereby restoring antitumor immunity. These findings provide a preclinical rationale for USP7 inhibition as a novel immunotherapeutic strategy for colorectal cancer, particularly in microsatellite-stable disease.

Для цитирования: Jia Gang, Wang Yuanying, Zhou Weiwei, Huang Xiaomei, Song Zhiyu. Discovery of o-aminodiphenyl-based USP7 inhibitor for immune activation and antitumor response in colorectal cancer.. International immunopharmacology. 2025. DOI: 10.1016/j.intimp.2025.115732.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.